Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Pellagra, caused by niacin deficiency and presenting with photosensitivity, should be considered in patients with relevant symptoms and risk factors.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Different types of PCOS need specific diagnosis methods and treatments.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Animal research has greatly advanced dermatology.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Metformin can cause hair loss in some women with PCOS.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Female pattern hair loss does not significantly affect sexual dysfunction.